Open
₹0.00
Prev close
₹1,856.50
Day range
₹0 – ₹0
52W range
₹1,228.9 – ₹1,944
Volume
69.4K
Avg vol (20D)
2.6L
Mkt cap
₹34,880.29Cr
P/E TTM
37.7×
Trade EMCURE PHARMACEUTICALS L with Artha
Sign in to place orders, set alerts, and sync your watchlist.
Company Metrics
Revenue (ttm)₹9203.54 Cr
Net Income (ttm)₹0.00
Shares Out18.97 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date
Trading Metrics
Beta0.00
About EMCURE.NS
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolEMCURE.NS
Websitehttps://www.emcure.com
EMCURE.NS · NSE
News
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account